Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 8, Issue 10, 2010, Pages

[No Author Info available]

Author keywords

anti inflammatory cytokines; body weight; c12; Conjugated linoleic acid (CLA); health claims; immune defences; insulin sensitivity; isomers c9; lean body mass; pro inflammatory; t11 and t10

Indexed keywords

EID: 85016247903     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2010.1794     Document Type: Article

References (35)

1. Albers R, van der Wielen RP, Brink EJ, Hendriks HF, Dorovska-Taran VN and Mohede IC, 2003. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. European Journal of Clinical Nutrition, 57, 595–603.
2. Atkinson RL, 1999. Conjugated linoleic acid for altering body composition and treating obesity. In: Advances in conjugated linoleic acid research. Eds Yurawecz MP, Mossoba MM, Kramer JKG, Pariza MW and Nelson GJ. AOCS Press, Champaign, IL, 348–353.
3. Bassaganya-Riera J, Hontecillas-Magarzo R, Bregendahl K, Wannemuehler MJ and Zimmerman DR, 2001. Effects of dietary conjugated linoleic acid in nursery pigs of dirty and clean environments on growth, empty body composition, and immune competence. Journal of Animal Science, 79, 714–721.
4. Bassaganya-Riera J, Pogranichniy RM, Jobgen SC, Halbur PG, Yoon KJ, O'Shea M, Mohede I and Hontecillas R, 2003. Conjugated linoleic acid ameliorates viral infectivity in a pig model of virally induced immunosuppression. Journal of Nutrition, 133, 3204–3214.
5. Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F, Rohrer J, Benninghoff AU and Hontecillas R, 2004. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology, 127, 777–791.
6. Belury MA, Mahon A and Banni S, 2003. The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. Journal of Nutrition, 133, 257S–260S.
7. Berven G, Bye A, Hals O, Blankson H, Fagertun H, Thom E, Wadstein J and Gudmunsen O, 2000. Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. European Journal of Lipid Science and Technology, 102, 455–462.
8. Blankson H, Stakkestad JA, Fagerton H, Thom E, Wadstein J and Gudmundsen O, 2000. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. Journal of Nutrition, 130, 2943–2948.
9. Chung S, Brown JM, Provo JN, Hopkins R and McIntosh MK, 2005. Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. Journal of Biological Chemistry, 280, 38445–38456.
10. Eyjolfson V, Spriet LL and Dyck DJ, 2004. Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Medicine and Science in Sports and Exercise, 36, 814–820.
11. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H and Gudmundsen O, 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. American Journal of Clinical Nutrition, 79, 1118–1125.
12. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H and Gudmundsen O, 2005. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. Journal of Nutrition, 135, 778–784.
13. Gaullier JM, Halse J, Hoivik HO, Hoye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M and Gudmundsen O, 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition, 97, 550–560.
14. Kamphuis MM, Lejeune MP, Saris WH and Westerterp-Plantenga MS, 2003. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. International Journal of Obesity and Related Metabolic Disorder, 27, 840–847.
15. Kelley DS, Taylor PC, Rudolph IL, Benito P, Nelson GJ, Mackey BE and Erickson KL, 2000. Dietary conjugated linoleic acid did not alter immune status in young healthy women. Lipids, 35, 1065–1071.
16. Lambert EV, Goedecke JH, Bluett K, Heggie K, Claassen A, Rae DE, West S, Dugas J, Dugas L, Meltzeri S, Charlton K and Mohede I, 2007. Conjugated linoleic acid versus high-oleic acid sunflower oil: effects on energy metabolism, glucose tolerance, blood lipids, appetite and body composition in regularly exercising individuals. British Journal of Nutrition, 97, 1001–1011.
17. Larsen TM, Toubro S, Gudmundsen O and Astrup A, 2006. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. American Journal of Clinical Nutrition, 83, 606–612.
18. Lowery LM, Appicelli PA and Lemon PWR, 1998. Conjugated linoleic acid enhances muscle size and strength gains in novice bodybuilders. Medicine and Science in Sports and Exercise, 30, S182.
19. Malpuech-Brugere C, Verboeket-van de Venne WP, Mensink RP, Arnal MA, Morio B, Brandolini M, Saebo A, Lassel TS, Chardigny JM, Sebedio JL and Beaufrere B, 2004. Effects of two conjugated linoleic Acid isomers on body fat mass in overweight humans. Obesity Research, 12, 591–598.
20. Moloney F, Toomey S, Noone E, Nugent A, Allan B, Loscher CE and Roche HM, 2007. Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes, 56, 574–582.
21. Moloney F, Yeow TP, Mullen A, Nolan JJ and Roche HM, 2004. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. American Journal of Clinical Nutrition, 80, 887–895.
22. Mougios V, Matsakas A, Petridou A, Ring S, Sagredos A, Melissopoulou A, Tsigilis N and Nikolaidis M, 2001. Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. Journal of Nutritional Biochemistry, 12, 585–594.
23. Petridou A, Mougios V and Sagredos A, 2003. Supplementation with CLA: isomer incorporation into serum lipids and effect on body fat of women. Lipids, 38, 805–811.
24. Pinkoski C, Chilibeck PD, Candow DG, Esliger D, Ewaschuk JB, Facci M, Farthing JP and Zello GA, 2006. The effects of conjugated linoleic acid supplementation during resistance training. Medicine and Science in Sports and Exercise, 38, 339–348.
25. Riserus U, Arner P, Brismar K and Vessby B, 2002. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care, 25, 1516–1521.
26. Smedman A and Vessby B, 2001. Conjugated linoleic acid supplementation in humans-metabolic effects. Lipids, 36, 773–781.
27. Song HJ, Grant I, Rotondo D, Mohede I, Sattar N, Heys SD and Wahle KW, 2005. Effect of CLA supplementation on immune function in young healthy volunteers. European Journal of Clinical Nutrition, 59, 508–517.
28. Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, Albright CD and Thuillier P, 2007. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. Journal of Nutrition, 137, 1188–1193.
29. Syvertsen C, Halse J, Hoivik HO, Gaullier JM, Nurminiemi M, Kristiansen K, Einerhand A, O'Shea M and Gudmundsen O, 2007. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. International Journal of Obesity (Lond), 31, 1148–1154.
30. Taylor JS, Williams SR, Rhys R, James P and Frenneaux MP, 2006. Conjugated linoleic acid impairs endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 307–312.
31. Tricon S, Burdge GC, Kew S, Banerjee T, Russell JJ, Grimble RF, Williams CM, Calder PC and Yaqoob P, 2004. Effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on immune cell function in healthy humans. American Journal of Clinical Nutrition, 80, 1626–1633.
32. Watras AC, Buchholz AC, Close RN, Zhang Z and Schoeller DA, 2007. The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. International Journal of Obesity, 31, 481–7.
33. Whigham LD, O'Shea M, Mohede IC, Walaski HP and Atkinson RL, 2004. Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. Food and Chemical Toxicology, 42, 1701–9.
34. Whigham LD, Watras AC and Schoeller DA, 2007. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. American Journal of Clinical Nutrition, 85, 1203–1211.
35. Yu L, 2001. Free radical scavenging properties of conjugated linoleic acids. Journal of Agricultural and Food Chemistry, 49, 3452–3456.